Counterpart to Registration Rights Agreement for 5.375% Senior Notes due 2023 (Endo Finance LLC, Endo Finco Inc., Guarantors, Citigroup Global Markets Inc., RBC Capital Markets)

Summary

This agreement, dated December 22, 2014, is a counterpart to a Registration Rights Agreement originally dated June 30, 2014. It binds Boca Pharmacal, LLC, Dava International, LLC, and Dava Capital Management, Inc. as Guarantors to the terms of the Registration Rights Agreement related to Endo Finance LLC and Endo Finco Inc.'s 5.375% Senior Notes due 2023. The Guarantors agree to be fully bound by the obligations and provisions of the original agreement, ensuring their participation in the registration process for the notes.

EX-10.210 6 ex10210rracounterpart53752.htm RRA 5.375% 2023 DEC 22 Ex. 10.210 RRA Counterpart 5.375% 2023

Exhibit 10.210

Counterpart to Registration Rights Agreement

December 22, 2014

Each of the undersigned hereby absolutely, unconditionally and irrevocably agrees as a Guarantor, as defined in the Registration Rights Agreement, dated June 30, 2014 by and among Endo Finance LLC, a Delaware limited liability company and Endo Finco Inc., a Delaware corporation, the Guarantors party thereto, Citigroup Global Markets Inc. and RBC Capital Markets, relating to the 5.375% Senior Notes due 2023, to be bound by the terms and provisions of such Registration Rights Agreement.

Exhibit 10.210

IN WITNESS WHEREOF, each of the undersigned has executed this counterpart as of the date first written above.



BOCA PHARMACAL, LLC, as a
by GENERICS INTERNATIONAL (US), INC., its
sole member



By:	/s/ Deanna Voss
	Name: Deanna Voss
	Title: Assistant Secretary



DAVA INTERNATIONAL, LLC, as a
by DAVA PHARMACEUTICALS, INC., its
sole member



By:	/s/ Deanna Voss
	Name: Deanna Voss
	Title: Assistant Secretary



DAVA CAPITAL MANAGEMENT, INC., as a



By:	/s/ Deanna Voss
	Name: Deanna Voss
	Title: Assistant Secretary